243 filings
Page 10 of 13
8-K
li135ya4y3gphjgy
6 May 21
InMed Pharmaceuticals to Report Third Quarter Fiscal 2021 Financial Results
7:30am
8-K
cbhtlxostelovz4gvk
4 May 21
InMed to Present at Canaccord Genuity’s 5th Annual Global Cannabis Conference on May 11th, 2021
11:10am
8-K
lggrw6 u83qr1wuk
28 Apr 21
Regulation FD Disclosure
1:31pm
8-K
iklhfz 3zs6mueeyr
28 Apr 21
Regulation FD Disclosure
11:43am
8-K
45b3e8dszpm zj9coh6f
27 Apr 21
Regulation FD Disclosure
4:22pm
EFFECT
toivo64qfr
16 Mar 21
Notice of effectiveness
12:15am
424B3
5dsg bfahn9u4t29
16 Mar 21
Prospectus supplement
12:00am
CORRESP
j7os4pdwf10v
11 Mar 21
Correspondence with SEC
12:00am
UPLOAD
ewe8lot
10 Mar 21
Letter from SEC
12:00am
S-8
4yvc75em
5 Mar 21
Registration of securities for employees
12:54pm
8-K
42ap1z1d8q9vbtexl yh
4 Mar 21
InMed to Present at Virtual Conferences in March 2021
3:21pm
8-K
tu6z30evi
3 Mar 21
Departure of Directors or Certain Officers
12:00am
8-K
jtt8v1dbq 1c5ec
16 Feb 21
InMed Announces Closing of US$4.5 Million Private Placement
6:12am
8-K
q7csi3l411ufbrth5lr
12 Feb 21
InMed Pharmaceuticals Reports Second Quarter Fiscal 2021 Financial Results
12:35pm
8-K
s83ozrdcm1ld0
5 Feb 21
InMed Announces US$4.5 Million Private Placement
5:28pm
8-K
w9z8 c1v42urbfzeg
20 Jan 21
Regulation FD Disclosure
3:43pm
8-K
imx34
19 Jan 21
Regulation FD Disclosure
2:42pm